RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$8.36B
1-Year Est. Return
49.23%
This Fund
S&P 500
1 Year Est. Return
+49.23%
AUM
$7.45B
AUM Growth
+$1.23B
(+20%)
Holding
84
Top Buys
| 1 | +$95.7M | |
| 2 | +$83.4M | |
| 3 | +$77M | |
| 4 |
Newell Brands
NWL
|
+$73.7M |
| 5 |
Eos Energy Enterprises
EOSE
|
+$70.5M |
Top Sells
| 1 | +$326M | |
| 2 | +$276M | |
| 3 | +$73.6M | |
| 4 |
Adaptive Biotechnologies
ADPT
|
+$72.9M |
| 5 |
COOP
Mr. Cooper
COOP
|
+$50.4M |
Sector Composition
| 1 | Healthcare | 36.98% |
| 2 | Utilities | 25% |
| 3 | Industrials | 15.36% |
| 4 | Energy | 6.88% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Russell 2000 ETF
IWM
$77.3B
| – | – |
0
|
|
||
77
Ovid Therapeutics
OVID
$480M
| – | – |
-478,533
|
|
||
78
PG&E
PCG
$37.2B
| – | – |
-3,600,000
|
|
||
79
State Street SPDR S&P 500 ETF Trust
SPY
$720B
| – | – |
0
|
|
||
80
Tesla
TSLA
$1.41T
| – | – |
0
|
|
||
81
Vistra
VST
$53.6B
| – | – |
-1,424,803
|
|
||
82
State Street SPDR S&P Biotech ETF
XBI
$8.55B
| – | – |
0
|
|
||
83
Zevra Therapeutics
ZVRA
$593M
| – | – |
-1,958,318
|
|